Abdallah Othman

Abdallah Othman Cardiovisual Content 🇪🇬 | Pharmaceutical Industry Professional

❤️Anterior View of the Human Heart Coronary Vasculature 🫀Dominant right coronary anatomy in clear view.Highlights the R...
30/09/2025

❤️Anterior View of the Human Heart Coronary Vasculature 🫀
Dominant right coronary anatomy in clear view.Highlights the RCA's acute marginal and conus branches, alongside the LAD and its diagonals.

Hypertension in Pregnancy: Management SnapshotChronic HTN:•1st-line: Labetalol PO, Nifedipine ER• Alternative: Methyldop...
30/09/2025

Hypertension in Pregnancy: Management Snapshot

Chronic HTN:
•1st-line: Labetalol PO, Nifedipine ER
• Alternative: Methyldopa
• HCTZ safe to continue

Severe HTN (SBP ≥160 / DBP ≥110):
•1st-line acute: Nifedipine IR PO, Labetalol IV, Hydralazine IV
• Specify max doses & monitoring

Absolute Contraindications:
•ACEi, ARB, Renin Inhibitors → Teratogenic
• Sublingual Nifedipine → Precipitous hypotension

Based on ACOG/ISSHP guidelines.


For educational purposes. Always consult full institutional protocols.

29/09/2025

Characteristic ECG Findings in Hypertrophic Cardiomyopathy (HCM)

🔹 LVH: Elevated QRS amplitude in limb/precordial leads, signaling increased myocardial mass.
🔹 Q Waves: Deep, narrow Qs in II, III, aVF, I, aVL, V5-V6, mimicking MI due to septal hypertrophy.
🔹 ST-T Changes: Depression & T-wave inversion in lateral leads, hinting at repolarization issues.
🔹 Left Atrial Enlargement: Notched/prolonged P waves in I, II, aVL, showing atrial remodeling.
🔹 Abnormal Q Waves: 25-50% of cases, tied to septal hypertrophy/fibrosis.
🔹 Giant Negative T Waves: Standout marker in apical HCM.
đź“š Source: Adapted from ACC/ESC 2025 Cardiac Imaging & Electrophysiology Standards.

OSA: A Major Modifiable CV Risk Factor. 💤🫀Strong evidence affirms OSA independently increases risk of:•Hypertension & HF...
29/09/2025

OSA: A Major Modifiable CV Risk Factor. 💤🫀

Strong evidence affirms OSA independently increases risk of:
•Hypertension & HF 🩺❤️
•AFib (4x) ⚡
•Stroke (3x) 🧠
•Nocturnal Sudden Death

Definitive management is crucial for cardiovascular risk reduction.

ACLS Pharmacotherapy Dosage, mechanism, and key administration notes for critical arrhythmias and arrest. A quick-refere...
28/09/2025

ACLS Pharmacotherapy Dosage, mechanism, and key administration notes for critical arrhythmias and arrest.
A quick-reference guide for the code team.

🎯Recognize these 11 high-risk ECG patterns suggestive of acute occlusion, which require urgent intervention:· Wellens Sy...
28/09/2025

🎯Recognize these 11 high-risk ECG patterns suggestive of acute occlusion, which require urgent intervention:

· Wellens Syndrome (A: Biphasic T-waves; B: Deeply inverted T-waves)
· de Winter T-waves (Upsloping ST depression & tall T-waves)
· Posterior STEMI (Horizontal ST depression V1-V4, tall R wave V2)
· Hyperacute T-waves (Tall, broad, asymmetrical T-waves)
· Sgarbossa Criteria (in LBBB/Paced Rhythm)
· Left Ventricular Hypertrophy Mimic (STE >25% S-wave)

Early recognition of these patterns is critical for timely reperfusion.

28/09/2025

ACLS Cardiac Arrest Algorithm:Shockable vs. Non-Shockable Rhythm Pathway

· Shockable: VF/VT. Treat with immediate defibrillation.
· Torsades de Pointes is a polymorphic VT. Defibrillate if pulseless. Correct underlying causes (e.g., hypomagnesemia, long QT).
· Non-Shockable: PEA/Asystole. Treat with CPR, Epinephrine, and reversible causes (Hs & Ts).

Cycle: 2 min CPR → Rhythm Check → Act.

How Modern HF Therapies Target Exercise PhysiologyCPET quantifies what our patients feel—the functional improvement from...
28/09/2025

How Modern HF Therapies Target Exercise Physiology

CPET quantifies what our patients feel—the functional improvement from guideline-directed medical therapy. Here's how key agents mechanistically enhance exercise performance:

➊ Central Hemodynamics & Oxygen Delivery
•ARNI / SGLT2i: Synergistically ↑ cardiac output & stroke volume, directly improving VO₂ peak and O₂ pulse.

âž‹ Ventilatory Efficiency & Gas Exchange
•ARNI / Vericiguat: Significantly improve VE/VCO₂ slope through enhanced pulmonary perfusion and reduced dead space ventilation.

➌ Metabolic Shift & Peripheral Utilization
•Combined GDMT: Elevates the anaerobic threshold, reflecting superior skeletal muscle oxygen extraction and utilization.

Emerging & Adjunctive Agents:
•Finerenone: Potential cardiorenal benefits under active investigation.
•GLP-1 RAs: Primarily address cardiometabolic co-morbidities.

The era of neurohormonal blockade has evolved into active multi-mechanistic optimization of exercise physiology. Comprehensive therapy is fundamental to improving functional status.



Informed by: 2022 AHA/ACC/HFSA Guidelines, Palau P et al. Rev Cardiovasc Med. 2023, & pivotal trials (PARADIGM-HF, DAPA-HF, EMPEROR-Reduced, VICTORIA).

Basic EKG/ECG Rhythms
27/09/2025

Basic EKG/ECG Rhythms


Hypertension: From Compensation to Heart Failure
26/09/2025

Hypertension: From Compensation to Heart Failure

The Heart's Vascular network.The heart's self-sustaining vascular circuit: coronary arteries perfuse the myocardium; car...
26/09/2025

The Heart's Vascular network.
The heart's self-sustaining vascular circuit: coronary arteries perfuse the myocardium; cardiac veins complete the return.

Management Algorithm for Tachycardia (With Pulse)A concise clinical pathway for managing a patient with a pulse but tach...
26/09/2025

Management Algorithm for Tachycardia (With Pulse)
A concise clinical pathway for managing a patient with a pulse but tachycardia, focusing on rapid assessment of stability and QRS morphology to guide treatment, including cardioversion, antiarrhythmics, and rate control.

Address

Mansoura

Telephone

+201004780764

Website

http://www.linkedin.com/in/abdallah-othman-b4092971

Alerts

Be the first to know and let us send you an email when Abdallah Othman posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Abdallah Othman:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

EPOFORM INDICATIONS Treatment of anemia due to concomitant myelosuppressive chemotherapy in patients with nonmyeloid malignancies; anemia due to chronic kidney disease in dialysis and nondialysis patients to decrease the need for RBC transfusion,Zidovudine-Treated HIV-Infected Patient.